ALNYLAM PHARMACEUTICALS, INC.
For the period ended May 8, 2025. Filed Mar 24, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 8, 2025 · Filed Mar 24, 2025
Contents
Proxy Statement Summary
This summary highlights important information you will find in this proxy statement. As it is only a summary, please review the complete proxy statement before you vote.
Virtual Annual Meeting Information
| Date: | Thursday, May 8, 2025 |
|---|---|
| Time: | 8:30 a.m., Eastern Time |
| Online at www.virtualshareholdermeeting.com/ALNY2025You will not be able to attend the annual meeting in person. | |
| Location: | |
| Record Date: | March 10, 2025 |
Voting Items and Board Recommendations
| Election of Four (4) Class III Directors | Approval of Charter Amendment Allowing for Officer Exculpation | Approval of Second Amended and Restated 2018 Stock Incentive Plan | Say-on-Pay—Advisory Vote on Approval of Executive Compensation | Ratification of Independent Auditors | ||||
| FOR ALL NOMINEES | FOR | FOR | FOR | FOR |
All proxies will be voted in accordance with the instructions contained in those proxies. If no choice is specified, the proxies will be voted in favor of the matters set forth in the accompanying Notice of Meeting. On any other matters properly brought before the annual meeting, the named proxies may vote in accordance with their best judgment.
How to Vote
| Vote Right Away Through Advance Voting Methods | Vote During Meeting | ||
|---|---|---|---|
| Vote by Internet Using Your ComputerGo to www.proxyvote. com and enter the 16-digit control number provided on your proxy card or voting instruction form. | Vote by TelephoneCall 1-800-690-6903 or the number on your proxy card or voting instruction form. You will need the 16-digit control number provided on your proxy card or voting instruction form. | Vote by MailIf you received printed proxy materials, complete, sign and date the proxy card or voting instruction form and mail it in the accompanying pre-addressed envelope. | Vote During the MeetingSee “Important Information About the Annual Meeting and Voting – Voting” for details on how to vote during the Annual Meeting. |
Proxy Statement Summary
Important Notice Regarding the Internet Availability of Proxy Materials for the Annual Meeting of Stockholders to be Held on May 8, 2025
We are furnishing proxy materials to our stockholders primarily via the Internet. On or about March 26, 2025, we will mail to our stockholders a Notice of Internet Availability containing instructions on how to access our proxy materials, including this proxy statement, our 2024 Annual Report on Form 10-K and our Annual Report to Stockholders. The Notice of Internet Availability also instructs you on how to submit your proxy or voting instructions through the Internet or to request a paper copy of our proxy materials, including a proxy card or voting instruction form that includes instructions on how to submit your proxy or voting instructions by mail or telephone. Other stockholders, in accordance with their prior requests, have received email access to our proxy materials and instructions to submit their vote via the Internet, or have been mailed paper copies of our proxy materials and a proxy card or voting instruction form.
This proxy statement, our 2024 Annual Report on Form 10-K and our Annual Report to Stockholders are available for viewing, printing and downloading atwww.proxyvote.com.
A copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as filed with the SEC on February 13, 2025, will be furnished without charge to any stockholder upon written request to Alnylam Pharmaceuticals, Inc., 675 West Kendall Street, Henri A. Termeer Square, Cambridge, Massachusetts 02142, Attention: Investor Relations and Corporate Communications.
This proxy statement and our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 are also available on the SEC’s website atwww.sec.gov.
| 2025 PROXY STATEMENT | 7 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.